SCHEMBL3823740

SCHEMBL3823740

NCCC(O)c1ccc(O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 5/20 0.68
HIF1A Q16665 2/20 0.68
HTR3A P46098 2/20 0.68
TSHR P16473 1/20 0.68
NFKB1 P19838 1/20 0.68
TDP1 Q9NUW8 6/20 0.65
KDM4E B2RXH2 4/20 0.65
APEX1 P27695 3/20 0.65
ALOX15 P16050 2/20 0.65
BLM P54132 4/20 0.50
ALDH1A1 P00352 2/20 0.50
HTR1A P08908 2/20 0.50
CYP2C9 P11712 2/20 0.50
THPO P40225 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NMUR2 Q9GZQ4 1/20 0.50
SLC6A2 P23975 2/20 0.43
CYP2C19 P33261 2/20 0.43
ADRA2A P08913 2/20 0.43
BACE1 P56817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6986294 0.98 TDP1 (0.69) TAAR1HIF1AHTR3ATSHRNFKB1
SCHEMBL7066863 0.83 TAAR1 (0.62) TAAR1HIF1AHTR3ATSHRNFKB1
Octopamine SCHEMBL1650462 0.81 TAAR1 (1.00) TAAR1HIF1AHTR3ATSHRNFKB1
Octopamine SCHEMBL22605 0.81 TAAR1 (1.00) TAAR1HIF1AHTR3ATSHRNFKB1
Octopamine SCHEMBL3489184 0.81 TAAR1 (1.00) TAAR1HIF1AHTR3ATSHRNFKB1
SCHEMBL8350845 0.80 AOC3 (0.53) TAAR1HIF1AHTR3ATSHRNFKB1
SCHEMBL21199026 0.80 AOC3 (0.53) TAAR1HIF1AHTR3ATSHRNFKB1
SCHEMBL21199024 0.80 AOC3 (0.53) TAAR1HIF1AHTR3ATSHRNFKB1
SCHEMBL6923821 0.80 TAAR1 (0.43) TAAR1HIF1AHTR3ATSHRNFKB1
SCHEMBL7350168 0.80 AOC3 (0.53) TAAR1HIF1AHTR3ATSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5120475-A Method for preparing microcapsules having improved pre-walls, and microcapsules and photosensitive materials produced thereby THE MEAD CORPORATION (US) 1992-06-09 US claimed
EP-3158053-A1 ACCELERATION OF MYCOBACTERIUM GROWTH St. George's Hospital Medical School (GB) 2017-04-26 EP disclosed
WO-2015193688-A1 ACCELERATION OF MYCOBACTERIUM GROWTH ST GEORGE'S HOSPITAL MEDICAL SCHOOL (GB) 2015-12-23 WO disclosed
EP-2061886-A1 SMALL CATIONIC ANTIMICROBIAL PEPTIDES The University of British Columbia (CA) 2009-05-27 EP disclosed
WO-2008151434-A1 SMALL CATIONIC ANTIMICROBIAL PEPTIDES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2008-12-18 WO disclosed
WO-2008022444-A1 SMALL CATIONIC ANTIMICROBIAL PEPTIDES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2008-02-28 WO disclosed
WO-2005109098-A1 PATTERN FORMING MATERIAL, PATTERN FORMING APPARATUS, AND PATTERN FORMING PROCESS FUJI PHOTO FILM CO., LTD. (JP) 2005-11-17 WO disclosed
WO-2005091078-A1 PATTERN FORMING PROCESS AND PATTERN FUJI PHOTO FILM CO., LTD. (JP) 2005-09-29 WO disclosed
WO-2005083522-A1 PATTERN FORMING PROCESS FUJI PHOTO FILM CO., LTD. (JP) 2005-09-09 WO disclosed
WO-2005078776-A1 PATTERN FORMING PROCESS FUJI PHOTO FILM CO., LTD. (JP) 2005-08-25 WO disclosed
EP-1286975-A1 BICLYCLIC CYCLOHEXYLAMINES AND THEIR USE AS NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 2003-03-05 EP disclosed
WO-2001092239-A1 BICICLIC CYCLOHEXYLAMINES AND THEIR USE AS NMDA RECEPTOR ANTOGONISTS WARNER-LAMBERT COMPANY (US) 2001-12-06 WO disclosed
US-5120475-A Method for preparing microcapsules having improved pre-walls, and microcapsules and photosensitive materials produced thereby THE MEAD CORPORATION (US) 1992-06-09 US disclosed
EP-0131824-A2 Photopolymerizable composition FUJI PHOTO FILM CO., LTD. (JP) 1985-01-23 EP disclosed
EP-0122151-A2 Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1984-10-17 EP disclosed